PFAS Lawsuit 2026: Claims, Settlements, and Who Qualifies

Quick Answer
– What it is: A PFAS lawsuit is a legal claim filed against manufacturers of per- and polyfluoroalkyl substances for contaminating drinking water and causing serious illness, including cancer.
– Who qualifies: People who drank PFAS-contaminated water, lived near a contaminated military base, or developed a qualifying cancer or disease after documented PFAS exposure.
– What it's worth: Individual personal injury claims have settled in ranges from $40,000 to over $250,000 depending on diagnosis severity; public water system settlements total more than $11 billion across two major defendant groups.

Case Snapshot

PFAS litigation is among the largest toxic tort actions in American legal history. Billions of dollars in settlements are already confirmed, yet personal injury claims for cancer and disease remain actively in trial preparation as of 2026.

The scale is worth stating plainly. More than 7,000 individual cases sit inside one federal MDL. Two separate settlement funds totaling over $11.4 billion have been established for contaminated public water systems alone. And new personal injury claims are still being filed.

This is also helpful: Thinx Lawsuit 2026: PFAS Claims, Settlement & Who Qualifies

This is not a single case. It is a coordinated legal system with distinct tracks, separate defendants, and very different compensation outcomes depending on what type of claim someone brings.

Understanding which track applies to your situation determines everything: which defendants you name, which court handles your case, and what the realistic compensation range looks like.

What Is a PFAS Lawsuit?

A PFAS lawsuit is a legal claim asserting that manufacturers of per- and polyfluoroalkyl substances caused personal injury, property damage, or water system contamination by releasing toxic chemicals they knew were dangerous.

PFAS compounds were used for decades in nonstick coatings, food packaging, firefighting foam, and industrial applications. The problem is chemical persistence. PFAS do not break down in the environment or in the human body, which is why they earned the name "forever chemicals."

The lawsuits allege that companies including 3M, DuPont, and their corporate successors knew about health risks and concealed them from regulators and the public for decades. Internal documents recovered in discovery strongly support that framing.

*Attorney Insight: Attorneys handling these claims point to internal corporate documents showing that manufacturers conducted their own toxicological studies as early as the 1970s and elected not to disclose the findings to health agencies.*

Key categories of PFAS lawsuits filed in 2026:

• Personal injury claims (cancer, thyroid disease, reproductive harm)
• Public drinking water contamination claims (filed by municipalities)
• Property damage and groundwater contamination claims
• Medical monitoring class actions

Litigation Watch: PFAS lawsuits span three distinct legal tracks with separate defendants and separate compensation structures; the track that applies to a claimant depends on their exposure type.

What Is a PFAS Class Action Lawsuit?

A PFAS class action lawsuit consolidates claims from a large group of plaintiffs who share a common exposure or injury into a single coordinated proceeding. Not all PFAS cases are class actions; many are individual personal injury cases filed and managed separately within MDL 2873.

True class actions in the PFAS context have been most successful on the medical monitoring theory. Courts in several states have certified class actions requiring defendant companies to fund medical screening programs for exposed populations, even when those individuals have not yet developed a diagnosed illness.

Personal injury claims for cancer, however, tend to proceed as individual cases rather than class-wide actions. Each plaintiff's exposure history, medical records, and disease progression are too fact-specific for a single class-wide trial.

*Attorney Insight: Attorneys handling medical monitoring class actions point to the distinction between "injury-in-fact" and "risk of future injury" as the central certification hurdle, with courts increasingly finding PFAS blood level elevation sufficient to establish standing.*

What Are the Latest PFAS Lawsuit Updates for 2026?

The most significant 2026 development is the continued advancement of the personal injury bellwether trial program under Judge Gergel's direct supervision. Bellwether trials function as test cases, producing verdicts that inform global settlement negotiations.

As of early 2026, the personal injury track is in active pretrial proceedings. Causation experts on both sides have submitted their Daubert briefings, and the plaintiffs' steering committee has identified the initial bellwether pool from the consolidated docket.

On the public water system side, 3M's $10.3 billion settlement and the DuPont/Chemours/Corteva $1.185 billion settlement are in the claims administration and allocation phase. Individual water utilities are receiving their calculated shares based on PFAS detection levels and remediation costs.

2026 PFAS litigation status by track:

*Attorney Insight: Attorneys tracking the MDL point to the bellwether trial schedule as the single most important pressure point for driving a global personal injury settlement in 2026 or early 2027.*

What Is MDL 2873 and How Does It Work?

MDL 2873 is the federal multidistrict litigation docket where the majority of PFAS-related lawsuits have been consolidated. It is formally styled *In re: Aqueous Film-Forming Foam Products Liability Litigation*, and it is pending before Judge Richard M. Gergel in the U.S. District Court for the District of South Carolina.

MDL consolidation is not the same as a class action. Individual plaintiffs retain their separate cases; those cases are grouped for pretrial purposes including coordinated discovery, expert witness proceedings, and motions practice. If the MDL does not settle globally, cases are remanded to their original federal districts for trial.

The docket was created by the Judicial Panel on Multidistrict Litigation in December 2018. What began with a handful of municipal water authority cases has grown to include more than 7,000 individual personal injury and water contamination claims.

MDL 2873 key structural facts:

• Presiding judge: Hon. Richard M. Gergel
• Court: D.S.C., Charleston Division
• Consolidation date: December 2018
• Primary defendants: 3M, DuPont, Chemours, Corteva, Tyco Fire Products, BASF, Kidde-Fenwal, Buckeye Fire Equipment
• Plaintiffs' steering committee: Appointed and active
• Case categories consolidated: Municipal water authority claims, personal injury claims, property damage claims

*Attorney Insight: Attorneys within the MDL structure point to the plaintiffs' steering committee's control over bellwether case selection as a critical strategic tool, because a favorable early verdict creates disproportionate settlement pressure on all defendants.*

Litigation Watch: MDL 2873 is the central federal docket for PFAS litigation; understanding its structure explains why a plaintiff's claim may be filed locally but litigated as part of a national coordinated proceeding.

What Is the 3M PFAS Lawsuit Settlement?

3M agreed to a $10.3 billion settlement with public water systems across the United States, announced in June 2023 and structured for payment over the period from 2024 through 2036. This settlement covers contamination of drinking water supplies by PFAS chemicals, primarily PFOS and PFOA, that were used in 3M's aqueous film-forming foam (AFFF) products.

The settlement does not cover personal injury claims for individuals who developed cancer or other diseases. It is strictly a public water system resolution. Individual personal injury cases against 3M remain pending within MDL 2873.

The $10.3 billion amount is distributed based on a formula that accounts for PFAS detection levels found in a water system and the remediation costs the utility has incurred or projected. Systems with higher contamination and greater filtration costs receive proportionally larger shares.

3M settlement key terms:

*Attorney Insight: Attorneys representing water utilities point to the detection-based allocation formula as both fair in principle and contentious in practice, because utility systems with older pre-filtration data face disputes over baseline contamination levels.*

What Is the DuPont PFAS Lawsuit?

DuPont's PFAS liability story is more complex than 3M's because of the corporate restructuring that created Chemours (spun off in 2015) and later Corteva Agriscience. The allocation of PFAS liability between these successor entities has been contested in court and remains an active dispute point in 2026.

DuPont, Chemours, and Corteva reached a combined $1.185 billion settlement with public water systems in 2023. Separately, DuPont and Chemours have faced ongoing litigation over which entity bears what share of personal injury liability for PFOA exposure, particularly related to the company's Washington Works plant in Parkersburg, West Virginia.

The "C8" PFOA litigation in West Virginia produced some of the earliest documented evidence linking DuPont's operations to cancer in exposed communities. That litigation, which concluded with a settlement in 2017, established the scientific and documentary record that now underpins much of the broader PFAS personal injury docket.

DuPont PFAS liability timeline:

*Attorney Insight: Attorneys handling DuPont-track claims point to the Chemours spin-off as a deliberate liability transfer mechanism, an argument that has gained traction in discovery and may affect future personal injury recoveries.*

Litigation Watch: The DuPont corporate restructuring created a layered liability dispute that continues to complicate both the allocation of settlement funds and the targeting of individual personal injury claims.

What Is the PFAS Firefighting Foam Lawsuit?

The PFAS firefighting foam lawsuit targets aqueous film-forming foam (AFFF), a product used for decades at military installations, commercial airports, and fire training facilities. AFFF is saturated with PFOS and PFOA compounds, and its use has contaminated groundwater around hundreds of sites nationwide.

This is the track that directly gives MDL 2873 its formal name. The AFFF claims are some of the most significant in the docket because the contamination footprint is enormous. The Department of Defense has identified more than 700 military installations where PFAS contamination has been detected in surrounding water sources.

Individuals who lived near military bases, worked at airports, or served as professional or military firefighters with documented AFFF exposure have standing to bring personal injury claims within this track. The defendants in this sub-track include manufacturers of the foam itself, including Tyco Fire Products, Kidde-Fenwal, Chemguard, and Buckeye Fire Equipment, as well as the upstream PFAS chemical suppliers.

AFFF exposure categories with standing:

• Military personnel at contaminated installations (Camp Lejeune overlaps here separately)
• Civilian firefighters who used AFFF during training or operations
• Residents of communities adjacent to military air stations
• Airport workers and firefighters at commercial aviation facilities
• Municipalities whose groundwater was contaminated by AFFF runoff

*Attorney Insight: Attorneys handling AFFF personal injury claims point to military discharge records and base-specific remediation reports as essential evidence in establishing both exposure duration and concentration levels.*

Which Cancers Qualify for a PFAS Cancer Lawsuit?

The cancers that qualify for a PFAS lawsuit are those for which peer-reviewed scientific literature and regulatory bodies have identified a probable or established causal link to PFOA or PFOS exposure. The plaintiff steering committee in MDL 2873 has worked with toxicologists and epidemiologists to establish which diagnoses meet the causation threshold required to survive Daubert challenges.

The strongest claims are those involving cancers where PFAS exposure has been recognized by bodies including the International Agency for Research on Cancer (IARC), which in 2023 classified PFOA as a Group 1 carcinogen (known human carcinogen) and PFOS as a Group 2B carcinogen (possible human carcinogen).

Also worth exploring: Capital One Lawsuit Settlement: Full 2026 Case Guide

Diagnoses currently associated with PFAS personal injury claims:

*Attorney Insight: Attorneys handling these claims point to the IARC's 2023 reclassification of PFOA as a definitive turning point in causation arguments, because Group 1 designation removes the primary defense that causation remains scientifically uncertain.*

Who Qualifies for a PFAS Lawsuit?

A person qualifies for a PFAS personal injury lawsuit if they can demonstrate documented exposure to PFAS chemicals and a medical diagnosis that is scientifically linked to that exposure. Both elements must be present. Exposure without illness, or illness without a traceable exposure source, generally does not produce a viable claim.

Exposure can be established through several sources: municipal water testing records showing PFAS above EPA limits, proximity to a known contamination site, military service at a documented PFAS-contaminated installation, or occupational contact with AFFF products.

PFAS lawsuit eligibility checklist:

*Attorney Insight: Attorneys evaluating new client cases point to water utility testing records submitted to the EPA's Safe Drinking Water Information System as the most reliable and legally defensible exposure documentation available to most plaintiffs.*

Litigation Watch: Qualifying for a PFAS lawsuit requires both documented exposure and a medically recognized diagnosis; exposure alone, without a current diagnosis, may support medical monitoring claims but typically not personal injury recovery.

What Are the Health Effects That Support a PFAS Lawsuit?

The health effects recognized as PFAS-related go beyond cancer. Decades of epidemiological research, including large-scale cohort studies from contaminated communities in West Virginia, Ohio, and Minnesota, have produced an extensive list of conditions associated with long-term PFAS exposure.

The EPA's 2024 National Primary Drinking Water Regulation for PFAS established maximum contaminant levels as low as 4 parts per trillion (ppt) for PFOA and PFOS individually. That standard acknowledges at the regulatory level that even extremely low concentrations carry health risk, which strengthens the causation argument in litigation.

Documented health effects associated with PFAS exposure:

• Kidney cancer (renal cell carcinoma)
• Testicular cancer
• Thyroid cancer and thyroid dysfunction
• Elevated cholesterol levels
• Pregnancy complications including preeclampsia and hypertension
• Immune system suppression (reduced vaccine efficacy in children)
• Developmental issues in children exposed in utero
• Ulcerative colitis
• Liver damage and elevated liver enzymes

*Attorney Insight: Attorneys handling pediatric exposure claims point to the immune suppression data as an underutilized legal theory, because reduced vaccine response in exposed children constitutes a measurable, documentable injury even without a cancer diagnosis.*

What Will the PFAS Settlement Pay in 2026?

PFAS settlement payouts in 2026 depend entirely on which litigation track applies to the claimant. Public water system settlements have established fixed allocation formulas. Personal injury settlements, by contrast, are individual negotiations or verdicts.

For personal injury claims, the resolution amounts vary based on diagnosis severity, exposure duration, age at diagnosis, and the strength of available exposure documentation. Based on resolved claims and publicly available information from analogous toxic tort litigations, individual PFAS personal injury settlements have ranged from approximately $40,000 on the low end to over $250,000 for severe, well-documented cases. Cases involving the strongest cancers (kidney, testicular) with clear exposure documentation have commanded higher values.

PFAS settlement payout structure (2026 overview):

*Attorney Insight: Attorneys negotiating personal injury resolution point to the bellwether trial schedule as the key settlement driver; defendants are more likely to offer full value on individual claims when a trial date is firm and discovery is complete.*

Litigation Watch: Personal injury PFAS payouts are individually negotiated and range widely based on diagnosis type, exposure documentation, and litigation stage; no single published figure applies universally.

How Much Is a PFAS Lawsuit Worth Per Person?

The per-person value of a PFAS lawsuit is not fixed by a single settlement grid. This distinguishes PFAS personal injury litigation from some mass tort resolutions, like the 3M earplug MDL, where a points-based matrix assigned dollar values to injury tiers.

In the PFAS personal injury track, individual case value turns on several factors evaluated by the plaintiffs' steering committee and, ultimately, by defense counsel during individual negotiations.

Factors that increase individual PFAS claim value:

*Attorney Insight: Attorneys valuing individual claims point to the "alternative causation" defense as the single biggest value-reduction risk, meaning defendants will identify every other potential cause of the plaintiff's illness and argue for apportionment.*

What Are the PFAS Lawsuit Filing Deadlines?

PFAS lawsuit filing deadlines are governed by each state's statute of limitations for personal injury or toxic tort claims, and they vary significantly. There is no single nationwide deadline, and this is one of the most consequential facts for any potential claimant.

Most states apply a statute of limitations of 2 to 3 years from the date a claimant knew or reasonably should have known of the connection between their illness and PFAS exposure. This is called the "discovery rule." In toxic tort cases, the discovery rule often starts the clock later than the actual diagnosis date, because the connection between exposure and illness may not be publicly known or medically established until later.

State statute of limitations for PFAS-related personal injury claims (representative examples):

Note: State law governs individual personal injury claims. Cases consolidated into MDL 2873 still remain subject to their originating state's limitations period for trial purposes.

*Attorney Insight: Attorneys reviewing potential PFAS claims point to the discovery rule as the most frequently misunderstood element, because many potential claimants assume their limitations period began at diagnosis rather than at the time they connected the diagnosis to documented PFAS exposure.*

How Do You File a PFAS Lawsuit?

Filing a PFAS lawsuit in 2026 requires retaining an attorney experienced in mass tort or toxic tort litigation. This is not a case category where self-representation is realistic or advisable.

Once retained, the attorney will evaluate your exposure history, request relevant water utility testing records, obtain your medical records, and assess whether your diagnosis falls within the causation framework accepted in MDL 2873. If your case qualifies, it will typically be filed in the appropriate federal district court, then transferred to MDL 2873 in the District of South Carolina.

The PFAS lawsuit filing process:

*Attorney Insight: Attorneys handling new PFAS case intakes point to water utility records and blood PFAS testing as the two most useful pieces of initial documentation, because they establish both the exposure event and the biological evidence of absorption.*

Which States Are Most Active in PFAS Lawsuit Litigation?

PFAS contamination is a national problem, but some states have both higher contamination rates and more active litigation environments. State-level lawsuits, filed by state attorneys general or individual plaintiffs, often run parallel to the federal MDL.

States that have filed or settled significant PFAS-related legal actions include Michigan, New Jersey, Minnesota, North Carolina, New Hampshire, Ohio, California, and West Virginia. Several of these states have also enacted state-specific PFAS drinking water standards that are more stringent than federal EPA levels, which strengthens the evidentiary record for plaintiffs in those jurisdictions.

States with the highest PFAS litigation activity (2026):

*Attorney Insight: Attorneys in high-activity states point to the presence of state-level enforcement actions as both a litigation tool and a documentation source, because state agency testing records are often more detailed than EPA-level data.*

What Is the Status of PFAS Drinking Water Lawsuits?

PFAS drinking water lawsuits filed by municipalities and public water utilities form the settled portion of the litigation. Both the 3M and DuPont/Chemours/Corteva settlements address contamination of public drinking water systems specifically.

The EPA's 2024 National Primary Drinking Water Regulation establishing maximum contaminant levels of 4 ppt for PFOA and PFOS created immediate compliance obligations for water utilities nationwide. That regulation also established a legal benchmark that strengthens future claims by utilities that now must spend billions on filtration and treatment upgrades.

You may want to read SHRM Lawsuit 2026: Claims, Payouts & Who Qualifies

Water utilities that accepted settlement payments were required to release defendants from future public water system contamination claims. However, utilities that opted out, or future utilities not yet covered by settlement terms, may retain claims. And individual residents served by contaminated systems retain separate personal injury rights regardless of whether their utility settled.

PFAS drinking water lawsuit status by defendant (2026):

*Attorney Insight: Attorneys representing municipalities point to the opt-out provisions in both major settlements as leverage for utilities that can document contamination costs exceeding their allocated settlement share.*

Litigation Watch: Municipal water system settlements do not release defendants from personal injury claims by individual residents, meaning both tracks can proceed simultaneously for the same contaminated community.

What Type of Attorney Handles a PFAS Lawsuit?

A PFAS lawsuit is handled by a mass tort attorney or toxic tort attorney, not a general personal injury practitioner. The distinction matters because PFAS litigation requires familiarity with MDL 2873's procedural rules, the plaintiffs' steering committee's case selection criteria, and the expert causation framework that has been developed over years of coordinated litigation.

Mass tort attorneys typically work on contingency, meaning the client pays no upfront legal fees. The attorney's fee, generally 33% to 40% of the recovery, is deducted from any settlement or verdict. If no recovery is obtained, no fee is owed.

When evaluating a PFAS attorney, potential claimants should look for:

What to look for in a PFAS lawsuit attorney:

• Demonstrated experience in MDL or mass tort litigation (not just general personal injury)
• Familiarity with the specific causation science (IARC classifications, EPA standards)
• Track record handling environmental or toxic tort cases
• Active involvement in MDL 2873 or a co-counsel relationship with firms in the MDL
• Contingency fee structure with no upfront cost
• Ability to obtain and analyze water utility testing records and medical documentation

*Attorney Insight: Attorneys practicing in this space point to co-counsel arrangements as a practical solution for claimants in smaller markets, where a local attorney partners with a firm active in the MDL to ensure the client gets both national litigation expertise and local access.*

Frequently Asked Questions

What is a PFAS lawsuit and who can file one?

A PFAS lawsuit is a civil claim against manufacturers of per- and polyfluoroalkyl substances for causing harm through chemical contamination of drinking water or direct product exposure.

Any person who can document both PFAS exposure and a medically recognized injury or diagnosis may file a claim.

Public water utilities may also bring separate contamination and remediation cost claims.

What is MDL 2873 and how does it affect my PFAS claim?

MDL 2873, formally *In re: Aqueous Film-Forming Foam Products Liability Litigation*, is the federal multidistrict litigation consolidating most U.S. PFAS lawsuits before Judge Richard M. Gergel in the District of South Carolina.

If you file a PFAS personal injury lawsuit in federal court, it will likely be transferred to MDL 2873 for coordinated pretrial proceedings.

Your case remains individually yours; MDL consolidation organizes pretrial work but does not eliminate your individual claim.

How much money can I get from a PFAS lawsuit settlement?

Individual PFAS personal injury settlements have ranged from approximately $40,000 to over $250,000, depending on diagnosis severity and the strength of exposure documentation.

Public water system settlements are calculated by a formula based on contamination levels and remediation costs, not individual payout amounts.

Final values depend on your specific diagnosis, exposure history, and how far your case progresses in litigation.

What cancers and diseases qualify for a PFAS personal injury claim?

The strongest qualifying diagnoses are kidney (renal cell) carcinoma and testicular cancer, for which IARC has classified PFOA as a Group 1 known carcinogen.

Thyroid cancer, bladder cancer, non-Hodgkin lymphoma, and ulcerative colitis are among the additional recognized qualifying conditions.

Non-cancer diagnoses including thyroid dysfunction, elevated cholesterol, and pregnancy complications may also support claims depending on state law and exposure documentation.

What is the filing deadline for a PFAS lawsuit in 2026?

There is no single national deadline; each state's statute of limitations for toxic tort claims governs your case.

Most states allow 2 to 3 years from the date you knew or reasonably should have known about the connection between your illness and PFAS exposure.

Waiting is the most common reason valid claims are lost, so a consultation with a mass tort attorney should happen as soon as a qualifying diagnosis exists.

Do I need a lawyer to file a PFAS class action lawsuit?

Yes. PFAS litigation requires an attorney with experience in multidistrict litigation, toxic tort causation science, and the specific procedural framework of MDL 2873.

Personal injury claims are individually negotiated and require a legal advocate familiar with the MDL's case valuation norms.

Mass tort attorneys handle these cases on contingency, meaning no upfront fees are required from the client.

The Path Forward in 2026

PFAS litigation entered 2026 with more than $11 billion in confirmed public water system settlements and an active personal injury track moving toward bellwether trials. For individuals with qualifying diagnoses, this is one of the most significant windows of opportunity in the litigation's history.

The progression of the bellwether trial program will define what individual personal injury claims are worth. Favorable verdicts in early bellwether cases typically accelerate global settlement negotiations and improve individual recovery amounts.

Anyone who believes they qualify should speak with a mass tort or toxic tort attorney who is active in MDL 2873 litigation. The statute of limitations analysis alone makes early consultation essential.

A related guide: Mike Tyson $50 Million Lawsuit: 2026 Case Guide